What is the main difference between Influenza A and B?

Influenza A infects humans and animals like birds and pigs, while Influenza B exclusively infects humans, and A causes most seasonal epidemics.

Which is worse, Influenza A or B?

Neither is inherently worse; both cause similar illness severity, but Influenza A often triggers more widespread seasonal outbreaks and can infect animals.

Can you get Influenza B if you already had Influenza A?

Yes, you can get Influenza B after Influenza A because they are distinct virus types, and immunity to one does not protect against the other.

Is the flu shot effective against both Influenza A and B?

Yes, the seasonal flu vaccine targets both Influenza A and B strains, though its effectiveness varies each year depending on strain matching.

What are the common symptoms of Influenza A versus B?

Both Influenza A and B cause fever, cough, sore throat, and muscle aches, with virtually identical symptoms that are indistinguishable without a lab test.

Can you switch from treating Influenza A to treating Influenza B?

Yes, you can switch antiviral medications like oseltamivir between types because the same prescription drug treats both Influenza A and B infections.

Which type of influenza is more dangerous for children, A or B?

Influenza B is often more dangerous for children, as it disproportionately causes severe complications in pediatric populations compared to Influenza A.

How long does Influenza A last compared to Influenza B?

Both Influenza A and B typically last 5 to 7 days, with similar timelines for fever resolution and symptom recovery in healthy adults.

What is the most common beginner mistake when distinguishing Influenza A and B?

The most common beginner mistake is assuming Influenza A is always more severe, when actually B can cause equally serious illness, especially in children.

Can a rapid test reliably tell you if you have Influenza A or B?

Yes, rapid antigen tests can reliably distinguish Influenza A from B, but they have moderate sensitivity and may miss infections compared to PCR testing.

Difference Between

Difference Between Influenza a and B

Written byNex Virox Team

Editorial Team

Reviewed byVarshal Nirbhavane

Senior SEO & Organic Growth Professional · 5+ years

Published: August 25, 202617 min read

Quick answer

The main difference between Influenza a and B is that Influenza a infects humans and animals, causing most seasonal epidemics and pandemics, while B infects only humans, causing milder, seasonal outbreaks. Influenza a is a broad viral type with multiple subtypes, while B is a narrower viral type with two main lineages.

Key takeaways

Core distinction: Influenza A originates from animals and causes pandemics, while B only infects humans.
How each works: Influenza A mutates rapidly via antigenic shift, whereas B evolves slowly through antigenic drift.
Seasonal impact: Influenza A dominates early-season outbreaks, but B peaks later and hits children harder.
Severity and treatment: Both cause similar flu symptoms, yet A often leads to more severe complications.
Best-fit use case: Annual flu vaccines protect against both types, so testing distinguishes them for antiviral care.

Table of Contents18 sections

Difference Between Influenza a and B: Comparison Table

Aspect	Influenza a	B
Definition	Causes seasonal flu epidemics and occasional pandemics in humans and animals.	Causes seasonal flu epidemics only, primarily affecting humans.
Primary Hosts	Infects humans, birds, pigs, horses, and other mammals.	Infects almost exclusively humans, with no known animal reservoir.
Subtypes	Classified by H and N surface proteins, such as H1N1 and H3N2.	Divided into two main lineages, Victoria and Yamagata.
Genetic Mutation	Undergoes both antigenic drift and shift, enabling rapid genetic change.	Undergoes antigenic drift only, changing more slowly and predictably.
Pandemic Potential	Capable of causing pandemics due to major genetic reassortment events.	Never causes pandemics because it lacks animal reservoirs for reassortment.
Transmission Mode	Spreads via respiratory droplets and contact with contaminated surfaces.	Spreads via respiratory droplets and contact with contaminated surfaces.
Incubation Period	Typically 1 to 4 days after exposure before symptoms appear.	Typically 1 to 4 days after exposure before symptoms appear.
Symptom Onset	Often sudden, with rapid onset of fever, chills, and body aches.	Often sudden, with rapid onset of fever, chills, and body aches.
Fever Severity	Frequently high, often reaching 102°F to 104°F within 24 hours.	Frequently high, often reaching 102°F to 104°F within 24 hours.
Respiratory Symptoms	Includes dry cough, sore throat, and nasal congestion in most cases.	Includes dry cough, sore throat, and nasal congestion in most cases.
Systemic Symptoms	Prominent muscle aches, headache, and profound fatigue are common.	Prominent muscle aches, headache, and profound fatigue are common.
Gastrointestinal Signs	Nausea and vomiting occur more often in children than adults.	Nausea and vomiting occur more often in children than adults.
Severity Range	Ranges from mild illness to severe pneumonia requiring hospitalization.	Ranges from mild illness to severe pneumonia requiring hospitalization.
High-Risk Groups	Severe outcomes more common in elderly, young children, and immunocompromised.	Severe outcomes more common in elderly, young children, and immunocompromised.
Pediatric Impact	Children under 5 face higher hospitalization rates than older age groups.	Children under 5 face higher hospitalization rates than older age groups.
Elderly Impact	Adults over 65 account for most seasonal flu-related deaths.	Adults over 65 account for most seasonal flu-related deaths.
Seasonal Timing	Circulates throughout winter months, peaking between December and February.	Circulates throughout winter months, peaking between December and February.
Epidemic Pattern	Often dominates early-season activity before B strains appear later.	Often peaks later in the season, sometimes after A subsides.
Laboratory Detection	Detected via RT-PCR, rapid antigen tests, or viral culture methods.	Detected via RT-PCR, rapid antigen tests, or viral culture methods.
Rapid Test Accuracy	Rapid tests show moderate sensitivity, missing many true positive cases.	Rapid tests show moderate sensitivity, missing many true positive cases.
Antiviral Treatment	Oseltamivir and zanamivir shorten illness when started within 48 hours.	Oseltamivir and zanamivir shorten illness when started within 48 hours.
Antiviral Resistance	Some strains show resistance to adamantanes, but neuraminidase inhibitors remain effective.	Resistance to neuraminidase inhibitors is rare and monitored continuously.
Vaccine Composition	Seasonal vaccines include two A subtypes, typically H1N1 and H3N2.	Seasonal vaccines include one or two B lineages, Victoria and Yamagata.
Vaccine Effectiveness	Effectiveness varies annually, ranging from 20% to 60% depending on match.	Effectiveness varies annually, ranging from 20% to 60% depending on match.
Zoonotic Spread	Transmits from birds and pigs to humans, causing sporadic infections.	Does not transmit from animals to humans under natural conditions.
Avian Strains	Includes H5N1 and H7N9 subtypes with high mortality in humans.	Has no avian or zoonotic equivalent strains.
Swine Strains	Includes H1N1 and H3N2 variants that circulate in pig populations.	Has no swine-associated variants.
Global Surveillance	Tracked year-round by WHO for pandemic preparedness and vaccine updates.	Tracked year-round by WHO for seasonal vaccine strain selection.
Mutation Rate	Mutates faster due to reassortment between different animal and human strains.	Mutates slower due to drift-only evolution in human hosts.
Best-Fit Scenario	Considered when severe outbreaks occur early or when animal exposure is suspected.	Considered when late-season cases persist after A activity declines.

What Is Influenza a?

Influenza A is a highly contagious respiratory virus that infects humans, birds, and pigs. It causes seasonal flu epidemics and occasional pandemics. Influenza A mutates rapidly, which is why it needs yearly vaccine updates.

Definition of Influenza a

Influenza A is an enveloped, negative-sense, single-stranded RNA virus of the Orthomyxoviridae family. It is classified by subtypes of hemagglutinin and neuraminidase surface proteins. This virus causes acute febrile respiratory illness with systemic symptoms.

Key Characteristics of Influenza a

Characteristic	What It Means in Practice
Broad host range	Infects humans, birds, swine, horses, and seals, enabling cross-species jumps.
Antigenic shift	Sudden genetic reassortment creates novel subtypes that can trigger pandemics.
Antigenic drift	Gradual surface protein mutations force annual vaccine reformulation.
Subtype diversity	H1N1 and H3N2 are the main human subtypes circulating each season.
Severe illness risk	Causes more hospitalisations and pneumonia complications than influenza B.
Rapid transmission	Spreads via droplets and aerosols from coughing, sneezing, or talking.
Short incubation	Symptoms appear one to four days after exposure to the virus.
Pandemic potential	New animal-origin subtypes can evade human immunity and spread globally.
Seasonal timing	Peaks in winter months in temperate regions, but circulates year-round in tropics.
Antiviral sensitivity	Responds to neuraminidase inhibitors when started within 48 hours of onset.

Common Examples of Influenza a

H1N1 - caused the 2009 swine flu pandemic and remains a seasonal strain.
H3N2 - a seasonal subtype linked to more severe illness in older adults.
H5N1 - avian influenza with high mortality in rare human spillover cases.
H7N9 - bird flu strain that caused human infections in China since 2013.
H1N2 - a swine-origin variant occasionally infecting humans through pig contact.
H3N8 - equine influenza that rarely transmits to humans from horses.
H9N2 - low-pathogenic avian virus that has caused mild human infections.
H10N3 - rare avian strain with a single reported human case in China.
H5N6 - avian virus causing severe human infections in Southeast Asia.
H7N7 - poultry virus that caused conjunctivitis in Dutch workers in 2003.

Advantages and Limitations of Influenza a

Advantages	Limitations
Fast immune response triggers within two weeks of vaccination.	Vaccine efficacy drops to 40-60% in mismatched seasons.
Antivirals like oseltamivir shorten illness duration when taken early.	Antiviral resistance emerges rapidly, especially to adamantane drugs.
Rapid diagnostic tests distinguish it from other respiratory viruses.	Rapid tests miss up to 30% of infections due to low sensitivity.
Seasonal vaccines reduce hospitalisation risk substantially in adults.	Vaccine production takes six months, lagging behind viral mutation.
Public health surveillance tracks subtypes to guide vaccine composition.	Zoonotic reservoirs make complete eradication biologically impossible.
Prior infection offers some cross-protection against related subtypes.	Cross-protection wanes within months and fails against novel subtypes.
Viral genome sequencing enables real-time outbreak monitoring.	Sequencing infrastructure is scarce in low-resource regions.
Hospital protocols reduce secondary bacterial pneumonia deaths.	Secondary bacterial infections still cause significant mortality in elderly patients.
School closures and masks reduce community transmission peaks.	Non-pharmaceutical measures cause economic disruption and are inconsistently applied.
Global pandemic preparedness systems exist for rapid response.	Preparedness funding is chronically under-resourced between pandemics.

What Is B?

B is a genus of influenza viruses that infects humans and seals. It causes seasonal flu epidemics, not pandemics. B mutates more slowly than A, making it more predictable. It exists as two main lineages that circulate globally each year.

Definition of B

Influenza B is a single-stranded RNA virus from the Orthomyxoviridae family. It is classified into Victoria and Yamagata lineages. Unlike influenza A, it does not have subtypes based on hemagglutinin and neuraminidase surface proteins. B primarily targets the human respiratory tract, causing seasonal outbreaks with significant morbidity.

Key Characteristics of B

Characteristic	What It Means in Practice
Host range	Infects humans and seals only, so it cannot cause animal-origin pandemics.
Mutation rate	Changes 2-3 times slower than A, giving vaccines longer-lasting effectiveness.
Lineages	Victoria and Yamagata strains alternate in dominance each flu season.
Surface proteins	Uses hemagglutinin and neuraminidase but without subtype variation like A.
Seasonality	Peaks in winter months in temperate regions, similar to influenza A.
Age impact	Hits school-age children hardest, unlike A which targets all ages evenly.
Antigenic drift	Accumulates small changes gradually, requiring annual vaccine updates.
Severity	Produces milder illness than A but still causes hospitalisation in vulnerable groups.
Vaccine coverage	Quadrivalent vaccines include both B lineages for broad protection.
Antiviral response	Responds to oseltamivir and baloxavir, same drugs used against influenza A.

Common Examples of B

B/Victoria - a lineage that dominated global flu seasons from 2019 to 2023, causing widespread outbreaks.
B/Yamagata - a lineage that circulated widely before 2020 but now appears nearly extinct globally.
B/Brisbane/60/2008 - a Victoria-lineage reference strain used in many seasonal flu vaccines.
B/Phuket/3073/2013 - a Yamagata-lineage strain included in quadrivalent vaccine formulations.
B/Wisconsin/1/2010 - a Yamagata strain that caused significant outbreaks in the 2011-2012 season.
B/Massachusetts/2/2012 - a Yamagata-lineage virus that drove vaccine strain updates in 2013.
B/Colorado/06/2017 - a Victoria-lineage strain that became dominant in the 2019-2020 US season.
B/Austria/1359417/2021 - a Victoria strain used in current quadrivalent vaccine recommendations.
B/Panama/45/1990 - a historical Victoria strain that circulated widely in the early 1990s.
B/Shanghai/1/2002 - a Yamagata-lineage reference strain used in older trivalent vaccines.

Advantages and Limitations of B

Advantages	Limitations
Slower mutation means vaccines remain effective for longer periods each season.	Still requires annual reformulation because drift accumulates over multiple years.
No pandemic potential since it cannot reassort with animal influenza viruses.	Can cause severe illness in children, leading to school outbreaks and paediatric hospitalisations.
Predictable seasonal patterns allow public health systems to prepare vaccination campaigns.	Yamagata lineage may be extinct, leaving vaccine manufacturers uncertain about future formulations.
Quadrivalent vaccines cover both lineages, reducing mismatch risk compared to older trivalent shots.	Antiviral resistance to oseltamivir can emerge, limiting treatment options in severe cases.
Milder symptoms than A mean lower mortality rates in healthy adults.	Diagnosis requires specific PCR tests because rapid antigen tests often miss B infections.
Stable surface proteins make it easier to track and predict circulating strains.	Vaccine effectiveness against B is often lower than against A in older adults.
Outbreaks are more localised, allowing targeted school closures rather than broad lockdowns.	Can still cause secondary bacterial pneumonia, especially in elderly and immunocompromised patients.
Natural immunity after infection lasts longer than with influenza A.	Co-infection with influenza A is possible, complicating treatment and worsening outcomes.
Surveillance data is robust, giving clear visibility into lineage shifts year to year.	Yamagata lineage disappearance may leave vaccines over-engineered and potentially less effective.
Response to neuraminidase inhibitors is generally consistent across circulating strains.	No universal vaccine exists, so protection depends entirely on annual seasonal shots.

Similarities Between Influenza a and B

Shared Aspect	How Influenza a and B Are Alike
Virus Category	Influenza a and B are both types of orthomyxoviruses that cause seasonal respiratory illness in humans.
Primary Hosts	Influenza a and B both infect humans as their primary natural hosts, spreading through respiratory droplets.
Transmission Route	Influenza a and B both spread from person to person via coughing, sneezing, or touching contaminated surfaces.
Infection Site	Influenza a and B both target and replicate within the epithelial cells lining the human respiratory tract.
Core Symptoms	Influenza a and B both trigger fever, cough, sore throat, body aches, and fatigue in infected individuals.
Onset Speed	Influenza a and B both have a sudden symptom onset, typically appearing one to four days after exposure.
Seasonal Pattern	Influenza a and B both circulate primarily during fall and winter months in temperate climate regions.
Incubation Period	Influenza a and B both share an incubation period of roughly two days before symptoms emerge.
Contagious Window	Influenza a and B both remain contagious from one day before symptoms start up to seven days later.
Diagnostic Method	Influenza a and B are both detected using the same rapid antigen tests or RT-PCR molecular assays.
Antiviral Drugs	Influenza a and B both respond to the same antiviral medications, including oseltamivir and zanamivir.
Vaccine Coverage	Influenza a and B are both included in the seasonal flu shot to provide protection against each strain.
Immune Response	Influenza a and B both trigger the body's adaptive immune system to produce specific antibodies.
Recovery Time	Influenza a and B both typically resolve within five to seven days for otherwise healthy individuals.
Complication Risk	Influenza a and B both can lead to pneumonia, bronchitis, or sinus infections in vulnerable patients.
High-Risk Groups	Influenza a and B both pose the greatest danger to young children, elderly adults, and pregnant women.
Prevention Hygiene	Influenza a and B both are prevented by frequent handwashing, mask wearing, and avoiding sick contacts.
Mutation Rate	Influenza a and B both undergo gradual antigenic drift that requires annual vaccine updates.
Global Burden	Influenza a and B both contribute to millions of annual infections and hundreds of thousands of hospitalizations worldwide.
Mortality Impact	Influenza a and B both cause thousands of seasonal deaths, especially among unvaccinated high-risk populations.
Symptom Duration	Influenza a and B both produce cough and fatigue that can linger for two weeks or longer.
Fever Pattern	Influenza a and B both typically cause high fever above 100.4°F that lasts for three to four days.
Pediatric Danger	Influenza a and B both can cause severe complications in children, including febrile seizures and dehydration.
Elderly Severity	Influenza a and B both often lead to more severe illness and higher hospitalization rates in seniors over 65.
Workplace Impact	Influenza a and B both cause significant employee absenteeism and productivity loss during peak season.
Testing Window	Influenza a and B both are best detected by swab tests within the first three to four days of symptoms.
Public Surveillance	Influenza a and B both are tracked by the same national and global influenza surveillance systems.
Home Care	Influenza a and B both are managed at home with rest, fluids, and over-the-counter fever reducers.
Herd Immunity	Influenza a and B both rely on high community vaccination rates to slow their spread effectively.
Long-Term Immunity	Influenza a and B both provide only short-lived immunity after infection, leaving people susceptible again.

Influenza a or B: Which Should You Choose?

You do not choose between Influenza a and B; the virus chooses for you. Both cause the same flu illness, but Influenza a drives seasonal epidemics and pandemics, while B causes milder, more localized outbreaks. Your decision is only about prevention and treatment timing.

When to Use Influenza a

Choose Influenza a when you need broad protection during peak winter months, as it infects humans, birds, and pigs and mutates faster. It dominates early-season cases and causes more severe symptoms in adults. Antiviral treatment like oseltamivir works best within 48 hours of symptom onset.

When to Use B

Choose B when cases appear in late winter or spring, as it only infects humans and spreads more slowly. It hits children and teenagers hardest and often causes milder illness in healthy adults. Annual vaccination remains your primary defense, since B strains change less rapidly than A strains.

Common Misconceptions About Influenza a and B

Common Myth	The Reality
Influenza a is always more severe than influenza b.	Influenza b can cause equally severe illness, hospitalization, and death, especially in children and older adults.
Influenza b only circulates in the spring season.	Influenza b circulates year-round but peaks later than influenza a, often in late winter or early spring.
You cannot get influenza b if you had influenza a.	Infection with influenza a does not protect you from influenza b because they are distinct virus types.
The flu shot only protects against influenza a strains.	Standard flu vaccines include both influenza a and influenza b strains to provide broad protection.
Influenza b is a milder version of the common cold.	Influenza b is a serious respiratory virus that can cause pneumonia, not a mild cold.
Only influenza a can cause pandemics in humans.	Influenza a causes pandemics, but influenza b still causes significant seasonal epidemics and severe outbreaks.
Influenza b does not mutate or change over time.	Influenza b mutates through antigenic drift, which is why vaccine strains are updated regularly.
Children rarely get infected with influenza b.	Influenza b disproportionately affects school-aged children and is a leading cause of pediatric flu hospitalizations.
Antiviral drugs like Tamiflu do not work on influenza b.	Oseltamivir (Tamiflu) is effective against both influenza a and influenza b when started within 48 hours.
Influenza a comes from animals, but influenza b only affects humans.	Influenza a has animal reservoirs, while influenza b primarily infects humans, making b less zoonotic.
Testing cannot tell the difference between influenza a and b.	PCR tests and rapid antigen tests can specifically identify whether influenza a or influenza b is present.
Influenza b symptoms are totally different from influenza a symptoms.	Influenza a and influenza b cause nearly identical symptoms like fever, cough, sore throat, and body aches.
You only need a flu shot if you are over 65 years old.	Influenza b and influenza a both pose serious risks to young children, pregnant women, and adults with chronic conditions.
Influenza b is less contagious than influenza a.	Influenza b spreads just as easily through droplets and has similar secondary attack rates in households.
Having influenza b gives you lifelong immunity.	Immunity from influenza b wanes over time, and you can be reinfected with different b strains.
Influenza a always starts with a sudden high fever.	Influenza a and influenza b both often start abruptly with fever, but some cases begin with mild symptoms.
Influenza b cannot cause complications like encephalitis.	Influenza b can cause rare neurological complications including encephalitis, seizures, and Reye syndrome in children.
Rapid flu tests are 100% accurate for distinguishing a from b.	Rapid tests have lower sensitivity, so false negatives occur for both influenza a and influenza b.
Influenza b is a new virus that emerged recently.	Influenza b has circulated in humans for decades and is divided into two lineages: Victoria and Yamagata.
You cannot catch influenza a and influenza b at the same time.	Co-infection with influenza a and influenza b is possible, though rare, and can lead to more severe illness.
Influenza b does not require medical attention ever.	Influenza b can cause severe dehydration, respiratory failure, and death, so medical care is sometimes essential.
The flu vaccine causes influenza b infection.	The flu vaccine contains inactivated or weakened virus, so it cannot cause influenza a or influenza b illness.
Influenza b only affects the respiratory system.	Influenza b can cause systemic effects like muscle inflammation, heart complications, and multi-organ failure.
Adults are more likely to die from influenza b than children.	Influenza b causes disproportionately higher mortality in children compared to influenza a in some seasons.
Influenza a is the only type that requires hospitalization.	Influenza b accounts for up to 30% of flu-related hospitalizations in some pediatric seasons.
You do not need antiviral treatment for influenza b.	Antiviral treatment for influenza b is recommended for high-risk patients, just as it is for influenza a.
Influenza b does not have distinct subtypes like influenza a.	Influenza b has two lineages, Victoria and Yamagata, which behave like subtypes and require vaccine coverage.
If your rapid test says influenza a, you cannot have b too.	Rapid tests detect one type per test; a separate test is needed to rule out co-infection with influenza b.
Influenza b is more common in tropical climates than temperate ones.	Influenza b shows less geographic variation than influenza a, but both circulate in tropical and temperate regions.
Recovering from influenza b means you are immune to influenza a.	Influenza b antibodies do not cross-protect against influenza a because the two viruses are antigenically distinct.

Conclusion

Difference Between Influenza a and B comes down to host range and severity. Influenza A infects humans, birds, and pigs, causing pandemics; Influenza B infects only humans, causing seasonal epidemics. Choose Influenza A for broader transmission risk. Choose Influenza B for typical seasonal flu management.

FAQs on Difference Between Influenza a and B

What is the main difference between Influenza A and B?: Influenza A infects humans and animals like birds and pigs, while Influenza B exclusively infects humans, and A causes most seasonal epidemics.
Which is worse, Influenza A or B?: Neither is inherently worse; both cause similar illness severity, but Influenza A often triggers more widespread seasonal outbreaks and can infect animals.
Can you get Influenza B if you already had Influenza A?: Yes, you can get Influenza B after Influenza A because they are distinct virus types, and immunity to one does not protect against the other.
Is the flu shot effective against both Influenza A and B?: Yes, the seasonal flu vaccine targets both Influenza A and B strains, though its effectiveness varies each year depending on strain matching.
What are the common symptoms of Influenza A versus B?: Both Influenza A and B cause fever, cough, sore throat, and muscle aches, with virtually identical symptoms that are indistinguishable without a lab test.
Can you switch from treating Influenza A to treating Influenza B?: Yes, you can switch antiviral medications like oseltamivir between types because the same prescription drug treats both Influenza A and B infections.
Which type of influenza is more dangerous for children, A or B?: Influenza B is often more dangerous for children, as it disproportionately causes severe complications in pediatric populations compared to Influenza A.
How long does Influenza A last compared to Influenza B?: Both Influenza A and B typically last 5 to 7 days, with similar timelines for fever resolution and symptom recovery in healthy adults.
What is the most common beginner mistake when distinguishing Influenza A and B?: The most common beginner mistake is assuming Influenza A is always more severe, when actually B can cause equally serious illness, especially in children.
Can a rapid test reliably tell you if you have Influenza A or B?: Yes, rapid antigen tests can reliably distinguish Influenza A from B, but they have moderate sensitivity and may miss infections compared to PCR testing.